Biotech Analysts See Deals, Drug Data Carrying 2020 Performance

(Bloomberg) -- Biotechnology analysts expect another strong performance in 2020 after stocks rose almost 25% this year.
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.